Found 53 matching trials
Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.
PHASE2Phase 2b clinical trial to evaluate the safety and efficacy of intranasal a...
Location
Gorgas Memorial Research Hospital
Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance
NAThis randomized controlled trial will compare strategies to reduce the risk...
Location
Covington Care Center
Impact of Mupirocin Decolonization on the Nasal Microbiome
N/AThe normal bacteria that inhabit the human nose, also known as the nasal mi...
Location
Veterans Affairs Eastern Colorado Healthcare System
Decolonization of Patients Carrying S. Aureus Before Cardiac Surgery: Study of the Risk Factors Associated With Failure
N/AStaphylococcus aureus nasal carriage is a well-known risk factor for S. aur...
Location
Chu Saint-Etienne
Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
NAThis study will prospectively evaluate the prevalence and incidence (over a...
Location
Naval Medical Center San Diego/Infectious Disease Division
Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric Study
PHASE1Mupirocin is an old antibiotic used topically since the 1970s. Initially us...
Status
Active Not Recruiting
Location
CHU de SAINT-ETIENNE
Active Bathing to Eliminate Infection (ABATE Infection) Trial
NAThe ABATE Infection Project is a cluster randomized trial of hospitals to c...
Location
West Hills Hospital & Medical Center
Bacterial Decolonization to Prevent Radiation Dermatitis
PHASE2The purpose of this study is to determine whether bacterial decolonization ...
Location
Montefiore Medical Center
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
PHASE2Purpose: There has been a recent, rapid increase in prevalence of Methicill...
Location
The Children's Hospital-University of Birmingham
Thermosensitive Gel Nasal Spray With Stem Cell Exosomes, Mupirocin, and DNase I for Chronic Sinusitis
EARLY_PHASE1This study tests a new nasal spray for adults (18-65 years) with chronic rh...
Location
Multiple Locations